You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Details for New Drug Application (NDA): 217030

✉ Email this page to a colleague

« Back to Dashboard

NDA 217030 describes PROBENECID AND COLCHICINE, which is a drug marketed by Ani Pharms, Beecham, Impax Labs, Novast Labs, Rising, and Sandoz, and is included in six NDAs. It is available from two suppliers. Additional details are available on the PROBENECID AND COLCHICINE profile page.

The generic ingredient in PROBENECID AND COLCHICINE is colchicine; probenecid. There are sixteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the colchicine; probenecid profile page.

Summary for 217030

Tradename:	PROBENECID AND COLCHICINE
Applicant:	Rising
Ingredient:	colchicine; probenecid
Patents:	0

Pharmacology for NDA: 217030

Suppliers and Packaging for NDA: 217030

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
PROBENECID AND COLCHICINE	colchicine; probenecid	TABLET;ORAL	217030	ANDA	Rising Pharma Holdings, Inc.	16571-832	16571-832-01	100 TABLET in 1 CONTAINER (16571-832-01)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	0.5MG;500MG
Approval Date:	Oct 24, 2023	TE:	AB	RLD:	No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.